86. Pulmonary arterial hypertension Clinical trials / Disease details

Clinical trials : 1,181 / Drugs : 701 - (DrugBank : 126) / Drug target genes : 105 - Drug target pathways : 192

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03229499 (ClinicalTrials.gov)	December 7, 2017	18/7/2017	Pulmonary Hypertension and Anastrozole Trial	Pulmonary Hypertension and Anastrozole Trial (PHANTOM)	Pulmonary Arterial Hypertension	Drug: Anastrozole;Drug: Placebo Oral Tablet	University of Pennsylvania	National Heart, Lung, and Blood Institute (NHLBI);Johns Hopkins University;University of Colorado, Denver;Rhode Island Hospital;Stanford University;Vanderbilt University;Washington University School of Medicine	Active, not recruiting	18 Years	N/A	All	84	Phase 2	United States
2	NCT01545336 (ClinicalTrials.gov)	October 2012	29/2/2012	Anastrozole in Patients With Pulmonary Arterial Hypertension	A Double-blind, Placebo-controlled Phase II Study of Anastrozole in Patients With Pulmonary Arterial Hypertension	Pulmonary Arterial Hypertension	Drug: Anastrozole;Drug: Placebo	University of Pennsylvania	NULL	Completed	18 Years	N/A	All	18	Phase 2	United States